Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 1
1995 3
1996 5
1997 1
1998 11
1999 4
2000 3
2001 5
2002 2
2003 8
2004 4
2005 2
2006 4
2007 4
2008 2
2009 1
2010 4
2011 1
2012 1
2014 1
2015 2
2016 1
2018 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: coffin rs. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
White paper on microbial anti-cancer therapy and prevention.
Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G. Forbes NS, et al. Among authors: coffin rs. J Immunother Cancer. 2018 Aug 6;6(1):78. doi: 10.1186/s40425-018-0381-3. J Immunother Cancer. 2018. PMID: 30081947 Free PMC article. Review.
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Thomas S, Kuncheria L, Roulstone V, Kyula JN, Mansfield D, Bommareddy PK, Smith H, Kaufman HL, Harrington KJ, Coffin RS. Thomas S, et al. Among authors: coffin rs. J Immunother Cancer. 2019 Aug 10;7(1):214. doi: 10.1186/s40425-019-0682-1. J Immunother Cancer. 2019. PMID: 31399043 Free PMC article.
From virotherapy to oncolytic immunotherapy: where are we now?
Coffin RS. Coffin RS. Curr Opin Virol. 2015 Aug;13:93-100. doi: 10.1016/j.coviro.2015.06.005. Epub 2015 Jun 26. Curr Opin Virol. 2015. PMID: 26121656 Review.
Oncolytic immunotherapy: an emerging new modality for the treatment of cancer.
Coffin RS. Coffin RS. Ann Oncol. 2016 Sep;27(9):1805-8. doi: 10.1093/annonc/mdw194. Epub 2016 May 10. Ann Oncol. 2016. PMID: 27166292 Free article. No abstract available.
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.
Hughes T, Coffin RS, Lilley CE, Ponce R, Kaufman HL. Hughes T, et al. Among authors: coffin rs. Oncolytic Virother. 2014 Jan 15;3:11-20. doi: 10.2147/OV.S36701. eCollection 2014. Oncolytic Virother. 2014. PMID: 27512660 Free PMC article. Review.
Herpes simplex virus vectors for the nervous system.
Lilley CE, Branston RH, Coffin RS. Lilley CE, et al. Among authors: coffin rs. Curr Gene Ther. 2001 Nov;1(4):339-58. doi: 10.2174/1566523013348346. Curr Gene Ther. 2001. PMID: 12109061 Review.
Viral vectors for gene therapy in Parkinson's disease.
Latchman DS, Coffin RS. Latchman DS, et al. Among authors: coffin rs. Rev Neurosci. 2001;12(1):69-78. doi: 10.1515/revneuro.2001.12.1.69. Rev Neurosci. 2001. PMID: 11236066 Review.
The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
Hunt D, Coffin RS, Anderson PN. Hunt D, et al. Among authors: coffin rs. J Neurocytol. 2002 Feb;31(2):93-120. doi: 10.1023/a:1023941421781. J Neurocytol. 2002. PMID: 12815233 Review.
76 results
Jump to page
Feedback